Comparison of treatment outcomes in community-acquired pneumonia patients treated with beta lactam-macrolide combination versus fluoroquinolone monotherapy
dc.contributor.author | Kilinc, O | |
dc.contributor.author | Soylar, O | |
dc.contributor.author | Cilli, A | |
dc.contributor.author | Sakar, A | |
dc.contributor.author | Tasbakan, S | |
dc.contributor.author | Ellidokuz, H | |
dc.contributor.author | Celenk, B | |
dc.contributor.author | Cetinkaya, C | |
dc.contributor.author | Gunduz, C | |
dc.contributor.author | Sayiner, A | |
dc.date.accessioned | 2025-04-10T10:36:03Z | |
dc.date.available | 2025-04-10T10:36:03Z | |
dc.identifier.e-issn | 1399-3003 | |
dc.identifier.issn | 0903-1936 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14701/41962 | |
dc.language.iso | English | |
dc.title | Comparison of treatment outcomes in community-acquired pneumonia patients treated with beta lactam-macrolide combination versus fluoroquinolone monotherapy | |
dc.type | Meeting Abstract |